Stentimplantation zur Behandlung der malignen oberen Einflussstauung

Felix A. Büstgens; Reinhard Loose; Joachim H. Ficker; Michael Wucherer; Michael Uder; Ralf Adamus

doi:10.1055/a-0623-4246

Gefäßmedizin Scan - Zeitschrift für Angiologie, Gefäßchirurgie, diagnostische und interventionelle Radiologie, Table of Contents

Gefäßmedizin Scan - Zeitschrift für Angiologie, Gefäßchirurgie, diagnostische und interventionelle Radiologie 2018; 05(02): 143-154
DOI: 10.1055/a-0623-4246

CME-Fortbildung

Stentimplantation zur Behandlung der malignen oberen Einflussstauung

Felix A. Büstgens

,

Reinhard Loose

,

Joachim H. Ficker

,

Michael Wucherer

,

Michael Uder

,

Ralf Adamus

Subject Editor: Wissenschaftlich verantwortlich gemäß Zertifizierungsbestimmungen für diesen Beitrag ist Herr Felix Büstgens.

Abstract

Dieser Artikel stellt die retrospektive Aufarbeitung der endovaskulären Therapie der oberen Einflussstauung bei vorliegender maligner Grunderkrankung vor. Vom klinischen Erfolg der Stentangioplastie, der Rezidivfreiheit, dem Überleben sowie möglichen Komplikationen wird berichtet. Für die Studie wurden Patientendaten von insgesamt 141 Patienten aufgearbeitet, bei denen Stents zur Therapie einer oberen Einflussstauung implantiert wurden.

Schlüsselwörter

endovaskuläre Stentimplantation - maligne oberen Einflussstauung - Bronchialkarzinom - Stenose - erhöhte Rezidivrate

Full Text

References

Literatur
1 Sigwart U, Puel J, Mirkovitch V. et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701-706
2 van Buuren F. 25. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Der Kardiologe 2010; 4: 502-508
3 Fusaro M, Cassese S, Ndrepepa G. et al. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials. JACC Cardiovasc Interv 2013; 6: 1284-1293
4 Scheinert D, Katsanos K, Zeller T. et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol 2012; 60: 2290-2295
5 Charnsangavej C, Carrasco CH, Wallace S. et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology 1986; 161: 295-298
6 Rosch J, Bedell JE, Putnam J. et al. Gianturco expandable wire stents in the treatment of superior vena cava syndrome recurring after maximum-tolerance radiation. Cancer 1987; 60: 1243-1246
7 Nicholson AA, Ettles DF, Arnold A. et al. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol 1997; 8: 781-788
8 Zollikofer CL, Antonucci F, Stuckmann G. et al. Use of the Wallstent in the venous system including hemodialysis-related stenoses. Cardiovasc Intervt Radiol 1992; 15: 334-341
9 Hennequin LM, Fade O, Fays JG. et al. Superior vena cava stent placement: results with the Wallstent endoprosthesis. Radiology 1995; 196: 353-361
10 Reechaipichitkul WTS. Etiology and outcome of superior vena cava (SVC) obstruction in adults. Southeast Asian J Trop Med Public Health 2004; 35: 453-457
11 Qanadli SD, El HajjamM, Mignon F. et al. Subacute and chronic benign superior vena cava obstructions: endovascular treatment with self-expanding metallic stents. Am J Roentgenol 1999; 173: 159-164
12 Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol) 2002; 14: 338-351
13 Escalante CP. Causes and management of superior vena cava syndrome. Oncology (Williston Park) 1993; 7: 61-68
14 Kee ST, Kinoshita L, Razavi MK. et al. Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology 1998; 206: 187-193
15 Furui S, Sawada S, Kuramoto K. et al. Gianturco stent placement in malignant caval obstruction: analysis of factors for predicting the outcome. Radiology 1995; 195: 147-152
16 Irving JD, Dondelinger RF, Reidy JF. et al. Gianturco self-expanding stents: clinical experience in the vena cava and large veins. Cardiovascular and interventional radiology 1992; 15: 328-333
17 Picquet J, Blin V, Dussaussoy C. et al. Surgical reconstruction of the superior vena cava system: indications and results. Surgery 2009; 145: 93-99
18 Cho Y, Gwon DI, Ko GY. et al. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?. Korean J Radiol 2014; 15: 87-94
19 Suzuki K, Asamura H, Watanabe S. et al. Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion. Ann Thorac Surg 2004; 78: 1184-1189
20 Smayra T, Otal P, Chabbert V. et al. Long-term results of endovascular stent placement in the superior caval venous system. Cardiovasc Inter Rad 2001; 24: 388-394
21 Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine 2006; 85: 37-42
22 Schifferdecker B, Shaw JA, Piemonte TC. et al. Nonmalignant superior vena cava syndrome: pathophysiology and management. Catheter Cardiovasc Intervent 2005; 65: 416-423
23 Rodrigues CI, Njo KH, Karim AB. Hypofractionated radiation therapy in the treatment of superior vena cava syndrome. Lung Cancer 1993; 10: 221-228
24 Chan RC, Chan YC, Cheng SW. Mid- and long-term follow-up experience in patients with malignant superior vena cava obstruction. Interactive cardiovascular and thoracic surgery 2013; 16: 455-458
25 Armstrong BA, Perez CA, Simpson JR. et al. Role of irradiation in the management of superior vena cava syndrome. Int J Radiation Oncol Biol Phys 1987; 13: 531-539
26 Urban T, Lebeau B, Chastang C. et al. Superior vena cava syndrome in small-cell lung cancer. Arch Intern Med 1993; 153: 384-387
27 Wurschmidt F, Bunemann H, Heilmann HP. Small-cell lung cancer with and without superior Vena cava syndrome – a multivariate analysis of prognostic factors in 408 cases. Int J Radiat Oncol 1995; 33: 77-82
28 Nguyen NP, Borok TL, Welsh J. et al. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax 2009; 64: 174-178
29 Uberoi R, Patel R, Cox P. et al. Im Internet: CIRSE Quality Assurance Guidelines for Superior Vena Cava Stenting in Malignant Disease. 2015 https://eu-csite-storage-prod.s3.amazonaws.com/www-cirse-org/files/files/CIRSE_QA_Guidelines_for_SVC_Stenting_in_Malignant_Disease_Revision_Uberoi_2016.pdf Stand: 25.02.2017
30 Monaco RG, Bertoni H, Pallota G. et al. Use of self-expanding vascular endoprostheses in superior vena cava syndrome. Eur J Cardiothorac Surg 2003; 24: 208-211